Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus
Open Access
- 5 October 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 15 (1), 48-56
- https://doi.org/10.1007/s11605-010-1358-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer PrognosisClinical Cancer Research, 2009
- MDM2 Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- The E-cadherin −347G→GA promoter polymorphism and its effect on transcriptional regulationCarcinogenesis: Integrative Cancer Research, 2004
- Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanNature Genetics, 2003
- Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent diseaseCancer, 2003
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- The recurrence pattern of esophageal carcinoma after transhiatal resectionJournal of the American College of Surgeons, 2000
- Molecular Genetic Changes in Metastatic Primary Barrett's Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett's AdenocarcinomaLaboratory Investigation, 2000
- Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal JunctionAnnals of Surgical Oncology, 1999